Without action by Congress, patients could lose access to essential laboratory services. Lacking ready access to lab tests, patients risk missed or delayed diagnoses, increased barriers to maintaining their health, and forgoing the opportunity to prevent even worse health outcomes or disease. A letter to Congressional leaders signed by AMT urged a one-year delay to the 2022 Medicare CLFS cuts and private payer data reporting period in the year-end package that is currently being negotiated.